Biogen, Inc. (BIIB)
182.61
+7.98
(+4.57%)
USD |
NASDAQ |
Jan 06, 16:00
183.00
+0.39
(+0.21%)
After-Hours: 20:00
Biogen Price: 182.61 for Jan. 6, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1064.04 |
| AbbVie, Inc. | 223.93 |
| Stoke Therapeutics, Inc. | 35.22 |
| Pfizer Inc. | 25.43 |
| Alnylam Pharmaceuticals, Inc. | 406.40 |
Price Related Metrics
| PE Ratio | 16.65 |
| PS Ratio | 2.763 |
| Price to Book Value | 1.471 |
| Price to Free Cash Flow | 11.84 |
| Earnings Yield | 6.00% |
| Market Cap | 26.79B |
| Operating PE Ratio | 10.98 |
| Normalized PE Ratio | 14.76 |